SCHEMBL19780263

SCHEMBL19780263

COCCNc1ncc(F)cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.40
ALDH1A1 P00352 5/20 0.40
CYP3A4 P08684 5/20 0.40
CYP1A2 P05177 5/20 0.40
HSD17B10 Q99714 4/20 0.40
CYP2C19 P33261 3/20 0.40
CLK4 Q9HAZ1 3/20 0.40
MAPK1 P28482 3/20 0.40
TSHR P16473 2/20 0.40
CYP2D6 P10635 1/20 0.40
ALOX15 P16050 1/20 0.40
CYP2C9 P11712 1/20 0.39
LMNA P02545 3/20 0.39
HTT P42858 1/20 0.39
KCNH3 Q9ULD8 1/20 0.39
USP2 O75604 1/20 0.39
APEX1 P27695 1/20 0.39
CASP7 P55210 1/20 0.39
FYN P06241 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23492902 0.83 LDHA (0.39) LDHAALDH1A1CYP3A4CYP1A2HSD17B10
SCHEMBL19880473 0.81 ALDH1A1 (0.39) LDHAALDH1A1CYP3A4CYP1A2HSD17B10
SCHEMBL22096832 0.80 ULK1 (0.38) LDHAALDH1A1CYP3A4CYP1A2HSD17B10
SCHEMBL19769042 0.80 P2RX3 (0.38) LDHAALDH1A1CYP3A4CYP1A2HSD17B10
SCHEMBL10731426 0.77 STK17A (0.51) SYK
SCHEMBL19779698 0.77 EGLN2 (0.43) LDHAALDH1A1CYP3A4CYP1A2HSD17B10
SCHEMBL16505576 0.73 LMNA (0.39) LDHAALDH1A1MAPK1LMNAHTT
SCHEMBL22597902 0.71 AGBL2 (0.42) ALDH1A1CYP3A4CYP1A2CYP2D6LMNA
SCHEMBL15008177 0.70 AGBL2 (0.41) ALDH1A1KDM4EAGBL2PIK3CA
SCHEMBL19779578 0.69 AGBL2 (0.45) ALDH1A1MAPK1HTTAGBL2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171492-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2021-06-10 US disclosed
US-10351547-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2019-07-16 US disclosed
US-20190002431-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2019-01-03 US disclosed
US-9896432-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2018-02-20 US disclosed
US-20180016252-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016252-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 LDHA 3305/4885ALDH1A1 4626/4885CYP3A4 4648/4885
US-10351547-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 LDHA 3305/4885ALDH1A1 4626/4885CYP3A4 4648/4885
US-20190002431-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 LDHA 3305/4885ALDH1A1 4626/4885CYP3A4 4648/4885
US-20210171492-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 LDHA 3305/4885ALDH1A1 4626/4885CYP3A4 4648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.